Atrial fibrillation – beyond drug therapies.
Anastasius M, Elsik M.
Cardiology Today 2014; 4(3): 6-12

Cardiac resynchronisation therapy: pacemaker versus internal cardioverter-defibrillator in patients with impaired left ventricular function.
Looi KL, Gajendragadkar PR, Khan FZ, Elsik M, Begley DA, Fynn SP, Grace AA, Heck PM, Virdee M, Agarwal S.
Heart. 2014 May;100(10):794-9

Utility of cardiac magnetic resonance imaging, echocardiography and electrocardiography for the prediction of clinical response and long-term survival following cardiac resynchronisation therapy.
Ellims AH, Pfluger H, Elsik M, Butler MJ, Hare JL, Taylor AJ.
Int J Cardiovasc Imaging. 2013 Aug;29(6):1303-11.

Long-term outcomes (>2 years) of atrial fibrillation ablation using a multi-electrode ablation catheter in patients with paroxysmal atrial fibrillation.
Looi KL, Gajendragadkar P, Taha T, Elsik M, Scully E, Heck P, Fynn S, Virdee M, Begley D. J Interv Card Electrophysiol. 2013 Jan;36(1):61-9

Supraventricular arrhythmias late after orthotopic cardiac transplantation: electrocardiographic and electrophysiological characterization and radiofrequency ablation.
M Elsik, A The, LH Ling, M Virdee, J Parameshwar, S Fynn, PM Kistler.
Europace. 2012 Oct;14(10):1498-505. Epub 2012 Apr 20. 

Targeted left ventricular lead placement to guide cardiac resynchonization therapy: A randomised controlled trial (TARGET study).
FZ Khan, MS Virdee, CR Palmer, PJ Pugh, D O’Halloran, M Elsik, PA Read, D Begley, SP Fynn, DP Dutka.
J Am Coll Cardiol. 2012 Apr 24;59(17):1509-18.

A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarction.
M Elsik, Y Zhang, B Wang, A Cox, D Kelly, H Krum.
Int J Cardiol. 2013 Sep 30;168(2):1174-85

Relation of peripheral collagen markers to death and hospitalisation in patients with heart failure and preserved ejection fraction: Results of the I-PRESERVE collagen sub-study.
H Krum, M Elsik, HG Schneider, A Ptaszynska, M Black, I Anand, P Carson, B Massie
Circulation Heart Failure. 2011 Sep;4(5):561-8

Antiphospholipid syndrome and rheumatic fever: a case spanning three decades of changing concepts and common immunological mechanisms.
Alcock R, Elsik M, Yiannikas C, Yiannikas J.
Lupus. 2011 Oct;20(12):1316-20

Effect of low amplitude 2D radial strain at left ventricular pacing sites on response to cardiac resynchronization.
FZ Khan, Virdee MS, Read PA, Pugh PJ, O’Halloran D, Fahey M, Elsik M, Begley D, Fynn SP, Dutka DP.
Journal Am. Soc. Echo. 2010 Nov;23(11):1168-76

The impact of RV lead position on response to cardiac resynchronization therapy and the feasibility of prospective targeting of LV lead placement to optimal sites.
FZ Khan, Read PA, Pugh PJ, Virdee MS, Elsik M, Begley D, Fynn SP, Dutka DP Pacing Clin Electrophysiol. 2011 Apr;34(4):467-74.

Combined dyssynchrony and scar imaging with cardiac magnetic resonance imaging predicts clinical response and long-term prognosis following cardiac resynchronization therapy.
A Taylor, M Elsik, A Broughton, J Cherayath, A Leet, C Wong, L Iles, M Butler, H Pfluger.
Europace 2010 May;12(5):708-13.

Differences between β-blockers in patients with Chronic Heart Failure and Chronic Obstructive Pulmonary Disease. Randomised Crossover Trial.
A Jabbour, P Macdonald, A Keogh, E Kotlyar, S Mellemkjaer, C Coleman, M Elsik, H Krum, C Hayward.
Journal of the American college of Cardiology. 2010 Apr 27; 55(17):1780-7.

Diagnostic characteristics of clozapine induced myocarditis.
K Ronaldson, JJ McNeil, AJ Taylor, M Elsik, PB Fitzgerald, DJ Topliss,
J Clin Psychiatry. 2010 Aug;71(8):976-81

Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.
Phrommintikul A, Haas SJ, Elsik M, Krum H. (Letter – Author Reply).
Lancet 2007. May 5;369(9572):1516-7.

Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.
Phrommintikul A, Haas SJ, Elsik M, Krum H.
Lancet. 2007 Feb 3;369(9559):381-8.

Predicting coronary artery bypass graft surgery in acute coronary syndromes.
Brieger D, Elsik M, Gore JM, Knobel E, Nussbacher A, Piegas LS, Allegrone J, Anderson FA, Avezum Á, on behalf of the Global Registry of Acute Coronary Events investigators.
EuroIntervention 2007;2:452–458.

Should beta blockers remain first-line drugs for hypertension?
Elsik M, Krum H.
Australian Prescriber 2007;30:5-7.

Atrial and ventricular echocardiographic correlates of the extent of pulmonary embolism in the elderly.
Chung T, Emmett L, Khoury V, Lau GT, Elsik M, Foo F, Allman KC, Kritharides L. J Am Soc Echocardiogr. 2006 Mar;19(3):347-53.

A pocket guide to the ECGs. 2nd edition – A book review.
M Elsik.
Australian Prescriber 2006 August;29(4):93.

Maros Elsik, H Krum.
ACE inhibitors and Angiotensin Receptor Blockers.
Coronary Care Manual. 2nd edition. 2010. Elsevier. Australia.

Maros Elsik, Simon P Fynn,
Permanent pacemakers and implantable defibrillators.
Core Topics in Cardiac Anesthesia, 2nd edition, 2012. Cambridge University Press. UK.